Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients

Clinical trial NCT06608641 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06608641
Sponsor: Jina Pharmaceuticals Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar 1 Disorder

Start date: 2024-03-19
Primary completion: 2025-06-01
Enrollment: 490

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.